Injectable weight-loss medication Ozempic has gained popularity, but its impact goes beyond weight loss. Research suggests it may also reduce addictive behaviors, lower Alzheimer’s disease risk, and help with ADHD symptoms.
The active ingredient in Ozempic, semaglutide, works by mimicking a natural hormone to regulate blood sugar and reduce appetite. This medication is used to treat type 2 diabetes and support weight loss. Emerging studies have found that it may curb addictive behaviors such as alcohol addiction and opioid overdose.
A 2024 study published in the scientific journal Addiction revealed people taking Ozempic had a 40% lower rate of opioid overdose compared to those not on the medication. Semaglutide is also linked to reducing cravings for other substances, including nicotine and ultra-processed foods.
In addition to its effects on addiction, Ozempic may help lower the risk of Alzheimer’s disease and dementia. A 2024 study found that semaglutide was associated with a 40% to 70% lower risk of an Alzheimer’s diagnosis over three years compared to other diabetes treatments.
Some research also suggests that taking Ozempic may soften ADHD symptoms, such as impulsivity and difficulty with focus. Furthermore, the medication has been linked to reduced cardiovascular disease risk, including heart attacks and strokes.
GLP-1 drugs like Ozempic have been found to reduce diagnoses of depression and anxiety by slowing gastric emptying and reducing gut inflammation. While side effects exist, patients often report increased calmness, satiety, and mental clarity while on the medication.
Source: https://www.standard.co.uk/lifestyle/ozempic-weight-loss-health-benefits-adhd-addiction-b1222610.html